Trial intelligence / Profile preview

Esketamine plus tramadol for PCIA after cesarean section

ChiCTR2200062848Phase 4Not yet recruiting

Sponsor
Pizhou People's Hospital
Start
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in postoperative pain and postpartum depression (PPD) (2 arms), sponsored by Pizhou People's Hospital. Primary endpoint: Numerical Rating Scale (NRS) pain score. Planned start Aug 2022; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

postoperative painpostpartum depression (PPD)

Beyond the preview

Go deeper on ChiCTR2200062848.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200062848.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call